Radna skupina za sigurnosne informacije i klinička ispitivanja

Voditeljica Radne skupine za sigurnosne informacije i klinička ispitivanja HFD-a:

Anja Kos Petrak, mag.pharm, Regulatory Affairs Director, Marti Farm;

Više informacija o angažmanu na

• 091 2420 869 (Anja Kos Petrak, mag. pharm., voditeljica Radne skupine) ili
• [email protected].

Članovi Izvršnog odbora Radne skupine za sigurnosne informacije i klinička ispitivanja HFD-a:

1. mr.sc. Tatjana Ajhler Đuretek dr. med., Head of Medical Affairs and Pharmacovigilance with role of EU QPPV, Belupo;
2. Ivona Bahnik, mag.pharm,  Pharmacovigilance Project Manager, PrimeVigilance;
3. Martina Diminić Smetiško,dr.med.dent, General Manager, QPPV,  Marti Farm;
4. Ana Gašpar Kozelj, dr.med., Regional Medical Advisor, Novo Nordisk;
5. Marta- Jela Gregorić, mag.pharm, Adria Head of Research, Abbvie;
6. Martino Grizelj, dr.med, Pharmacovigilance Manager,Pliva;
7. Katarina Gvozdanović, dipl.ing.med.biokem., Coordinator for Safety Assessment of Medicinal Products, HALMED;
8. Marina Lesičar, mag.pharm, Senior Associate for Pharmacovigilance and Rational Pharmacotherapy, HALMED;
9. Laura Markaj, mag.pharm, Head of pharmacovigilance department, Deputy of Qualified Person for Pharmacovigilance, Marti Farm;
10. Vanja Mikelić, mag.pharm, Senior Associate Global Safety,  Amgen;
11. Anita Vlašić, mag.pharm, Head of clinical trials department, KBC Zagreb;
12. Karina Vukelić, dr.med.spec., Vigilance and Medical Affairs Manager, JGL;